BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 30
• 31

• Drug Development

  Palatin Technologies And King Pharmaceuticals®, Inc. Complete Enrollment In Two Phase IIb Clinical Trials Evaluating Bremelanotide In Patients With Erectile Dysfunction

  May 4, 2006

   · 

  7 min read
• Drug Development

  Corgentech, Inc. Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief Of Pain And Improved Function In Elbow Tendonitis

  May 4, 2006

   · 

  7 min read
• Drug Development

  Serono International S.A. Release: Phase III Trial Of Oral Cladribine, A Novel Investigational Therapy For Multiple Sclerosis, Begins In The United States

  May 4, 2006

   · 

  6 min read
• Drug Development

  XenoPort, Inc. Announces Presentation Of XP13512 Data At The American Pain Society Meeting

  May 4, 2006

   · 

  5 min read
• Drug Development

  ISTA Pharmaceuticals, Inc. Announces Study Indicating Twice-Daily Dosing Of Xibrom(TM) As Equivalent To Four Times A Day Of Other Treatments

  May 4, 2006

   · 

  5 min read
• BioCapital

  AstraZeneca PLC Release: Combined Use Of ATACAND(R) (Candesartan Cilexetil) And ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone

  May 4, 2006

   · 

  6 min read
• Drug Development

  AstraZeneca PLC Pipeline Holed As Phase 3 Diabetes Drug Fails

  May 4, 2006

   · 

  1 min read
• BioMidwest

  Perrigo Company Acknowledges Barr Pharmaceuticals, Inc. Patent Challenge Of NASACORT(R) AQ Nasal Spray

  May 4, 2006

   · 

  3 min read
• Pharm Country

  Misonix Incorporated To Discuss Progress With Cancer Treating HIFU And Other Ultrasonic Medical Devices At Annual Long Island Life Sciences Industry Summit

  May 4, 2006

   · 

  4 min read
• Policy

  U.S. FDA Grants Fast Track Designation For Bioniche Life Sciences Inc. Bladder Cancer Product

  May 4, 2006

   · 

  3 min read